Abstract:A NT-3 sustained-release scaffold confers a microenvironment partially simulating the developmental spinal cord.The NT-3 microenvironment boosts neuronal differentiation of TrkC-modified NSCs by interactions between ligand and receptor.TrkC-NSCs is self-organized into a neural network tissue with typical neural excitability in 3D bioactive scaffold in vitro.The grafted neural network tissue can survive and maintain neural property, and improve motor function of paralyzed rats.The mechanism underlying neurogenesis during embryonic spinal cord development involves a specific ligand/receptor interaction, which may be help guide neuroengineering to boost stem cell-based neural regeneration for the structural and functional repair of spinal cord injury. Herein, we hypothesized that supplying spinal cord defects with an exogenous neural network in the NT-3/fibroin-coated gelatin sponge (NF-GS) scaffold might improve tissue repair efficacy. To test this, we engineered tropomyosin receptor kinase C (TrkC)-modified neural stem cell (NSC)-derived neural network tissue with robust viability within an NF-GS scaffold. When NSCs were genetically modified to overexpress TrkC, the NT-3 receptor, a functional neuronal population dominated the neural network tissue. The pro-regenerative niche allowed the long-term survival and phenotypic maintenance of the donor neural network tissue for up to 8 weeks in the injured spinal cord. Additionally, host nerve fibers regenerated into the graft, making synaptic connections with the donor neurons. Accordingly, motor function recovery was significantly improved in rats with spinal cord injury (SCI) that received TrkC-modified NSC-derived neural network tissue transplantation. Together, the results suggested that transplantation of the neural network tissue formed in the 3D bioactive scaffold may represent a valuable approach to study and develop therapies for SCI.Scheme 1. A neurotrophin-3 (NT-3) sustained-release bioscaffold supports the formation of tyrosine kinase receptor C (TrkC)-modified neural stem cell-derived neural network tissue with efficacy in repairing spinal cord injury.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X2100147X-ga1_lrg.jpg">Download : Download high-res image (306KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X2100147X-ga1.jpg">Download : Download full-size image</a></li></ol>

NT-3 Gene Modified Schwann Cells Promote TrkC Gene Modified Mesenchymal Stem Cells to Differentiate into Neuron-Like Cells in Vitro

NT-3 GENETICALLY MODIFIED SCHWANN CELLS PROMOTE GRAFTED NEURAL STEM CELLS DIFFERENTIATE INTO NEURON-LIKE CELLS IN THE INJURED SPINAL CORD

Human umbilical cord-derived Schwann-like cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury

An NT-3-releasing bioscaffold supports the formation of TrkC-modified neural stem cell-derived neural network tissue with efficacy in repairing spinal cord injury

Transplantation of tissue engineering neural network and formation of neuronal relay into the transected rat spinal cord

Integration of Donor Mesenchymal Stem Cell-Derived Neuron-Like Cells into Host Neural Network after Rat Spinal Cord Transection.

The effects of co-transplantation of NT-3 gene modified Schwann cells and TrkC gene modified bone marrow mesenchymal stem cells on the survival of neurons after rat's spinal cord transection

Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord.

Tissue-Engineered Regeneration of Completely Transected Spinal Cord Using Induced Neural Stem Cells and Gelatin-Electrospun Poly (Lactide-Co-Glycolide)/Polyethylene Glycol Scaffolds

Synaptic Transmission of Neural Stem Cells Seeded in 3-Dimensional Plga Scaffolds

Donor Mesenchymal Stem Cell-Derived Neural-Like Cells Transdifferentiate into Myelin-Forming Cells and Promote Axon Regeneration in Rat Spinal Cord Transection

Spinal cord injury-associated protein expression following neurotrophin-3 gene modified neural stem cells transplantation

Differentiation of Rat Bone Marrow Mesenchymal Stem Cells Into Neuron-Like Cells In Vitro and Co-Cultured with Biological Scaffold as Transplantation Carrier.

Neurotrophin-3 gene transduction of mouse neural stem cells promotes proliferation and neuronal differentiation in organotypic hippocampal slice cultures.

Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Overexpressing TrkC into Neuron-Like Cells in Transected Spinal Cord of Rats.

The Effects of Controlled Release of Neurotrophin-3 from PCLA Scaffolds on the Survival and Neuronal Differentiation of Transplanted Neural Stem Cells in a Rat Spinal Cord Injury Model.

Electro-Acupuncture Promotes the Survival and Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Pre-Induced with Neurotrophin-3 and Retinoic Acid in Gelatin Sponge Scaffold after Rat Spinal Cord Transection

Graft of the NT-3 Persistent Delivery Gelatin Sponge Scaffold Promotes Axon Regeneration, Attenuates Inflammation, and Induces Cell Migration in Rat and Canine with Spinal Cord Injury.

Transplantation of Neurotrophin-3 Modified Neural Stem Cell for Spinal Cord Injury Treatment in Rats

Neurotrophin-3 gene modified mesenchymal stem cells promote remyelination and functional recovery in the demyelinated spinal cord of rats.

Electroacupuncture Facilitates the Integration of a Grafted TrkC-modified Mesenchymal Stem Cell-Derived Neural Network into Transected Spinal Cord in Rats Via Increasing Neurotrophin-3.